Doctoral program


A coordinated effort with cooperation between health care providers, academic and private actors is crucial to increase the availability of people with specialist skills in ATMP in both the public and private sectors. This doctoral program is a node-based research school offering national education and training of teachers to enable high quality health care as well as future development of ATMPs in Sweden. The research school connects world-leading academic research environments with relevant health care education programs, health care providers, regulatory authorities, the pharmaceutical industry, and innovation ecosystems.

Coordinator: Lund University

Partners: Gothenburg University, Umeå University, Uppsala University, Karolinska Institutet

Course packages

  • Introductory course to cell and gene therapies
  • Quality control and regulatory aspects of ATMP
  • Molecular aspects of cell, tissue, and gene therapies
  • From lab protocol to GMP product
  • Medical law and legal aspects of ATMP
  • Designing, approval and conduction of ATMP clinical trials
  • Logistics/handling of cell and gene therapies
  • Patient access and health economics of ATMPs

Contact: Johan Flygare